Artemis Medicare Services Ltd (ARTEMISMED) share price, results

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	217	210	217	217	235	227	235	250	270	267	274	282
Expenses	184	179	181	181	193	190	199	209	220	223	224	227
Operating Profit	33	32	36	36	42	37	36	41	50	44	50	55
OPM %	15%	15%	17%	16%	18%	16%	15%	16%	19%	16%	18%	20%
Other Income	2	2	2	4	8	9	12	7	8	4	8	5
Interest	7	8	8	8	8	8	8	7	7	7	6	6
Depreciation	9	10	10	10	11	11	11	11	11	12	12	12
Profit before tax	19	16	19	22	31	27	29	30	40	30	39	42
Tax %	27%	29%	28%	24%	27%	23%	20%	29%	25%	24%	25%	26%
Net Profit	14	12	14	17	23	21	23	21	30	23	30	31
EPS in Rs	1.01	0.85	1.02	1.24	1.64	1.51	1.69	1.54	2.16	1.42	1.87	1.96

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	402	459	503	547	563	402	545	714	845	913	1,060	1,093
Expenses	359	406	442	480	501	367	477	620	717	763	875	893
Operating Profit	43	53	60	66	62	35	68	94	128	150	185	200
OPM %	11%	11%	12%	12%	11%	9%	12%	13%	15%	16%	17%	18%
Other Income	5	4	3	2	4	7	3	7	7	33	27	25
Interest	9	9	9	11	13	12	11	19	30	30	27	26
Depreciation	12	15	18	20	22	21	21	29	38	43	46	48
Profit before tax	27	32	35	37	32	9	39	53	68	109	139	151
Tax %	21%	16%	24%	44%	36%	20%	16%	25%	28%	24%	25%
Net Profit	22	27	27	21	20	7	33	40	49	83	103	113
EPS in Rs	1.03	1.29	1.27	0.98	1.54	0.54	2.46	2.96	3.62	6.07	6.53	7.41
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	15%	12%	7%	7%

	10 Years	5 Years	3 Years	TTM	1 Year	Last Year
Compounded Sales Growth	10%	21%	14%	15%
Compounded Profit Growth	17%	76%	40%	31%
Stock Price CAGR	%	60%	32%		59%
Return on Equity	10%	12%	12%			12%

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	21	21	21	21	0.00	13	13	13	13	14	14	16
Reserves	135	163	183	210	280	301	308	348	393	438	828	923
Borrowings	85	68	94	91	114	108	137	190	268	305	280	260
Other Liabilities	90	93	124	130	160	159	130	145	207	191	221	225
Total Liabilities	331	345	422	452	555	581	589	697	882	948	1,343	1,424
Fixed Assets	239	249	283	309	381	387	372	476	584	699	729	790
CWIP	0	1	27	43	49	56	81	64	95	33	40	33
Investments	0	0	0	0	0	2	4	6	12	15	15	15
Other Assets	91	94	112	100	124	137	132	152	192	200	559	585
Total Assets	331	345	422	452	555	581	589	697	882	948	1,343	1,424

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	53	20	58	72	41	56	27	61	129	108	150	129
Cash from Investing Activity	-10	-14	-74	-67	-50	-22	-34	-106	-153	-90	-396	-96
Cash from Financing Activity	-35	-24	19	-10	14	-33	12	44	30	-26	274	-41
Net Cash Flow	7	-18	3	-4	5	2	6	-2	7	-8	28	-8
Free Cash Flow	37	4	-17	11	-17	37	2	-45	-5	36	57	25
CFO/OP	127%	48%	112%	121%	76%	97%	71%	114%	140%	95%	109%	81%

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	39	49	48	40	52	50	48	47	43	36	37	38
Inventory Days	26	21	19
Days Payable	195	189	187
Cash Conversion Cycle	-129	-120	-120	40	52	50	48	47	43	36	37	38
Working Capital Days	-59	-31	-44	-53	-51	-36	-36	-25	-45	-29	-31	-19
ROCE %	14%	15%	16%	15%	14%	11%	4%	10%	11%	14%	15%	15%

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	68.03%	68.03%	68.03%	67.51%	67.17%	67.17%	67.17%	66.53%	66.53%	58.38%	58.39%	58.39%
FIIs	0.09%	0.11%	0.10%	0.16%	0.21%	0.65%	0.31%	0.24%	0.37%	12.47%	12.19%	12.28%
DIIs	1.51%	1.96%	2.61%	3.45%	3.60%	4.51%	5.04%	4.76%	4.27%	2.91%	2.89%	2.40%
Government	7.18%	7.18%	7.18%	7.12%	7.09%	7.09%	7.09%	7.02%	7.02%	6.16%	6.16%	6.16%
Public	23.18%	22.72%	22.08%	21.76%	21.93%	20.59%	20.39%	21.45%	21.81%	20.07%	20.37%	20.76%
No. of Shareholders	20,529	22,375	19,993	19,795	26,054	27,004	28,397	31,614	33,559	31,602	32,044	36,335

Fundamentals

Market Cap₹ 5,818 Cr.

Current Price₹ 367

Stock P/E50.4

Book Value₹ 59.3

ROCE14.5 %

ROE11.9 %

Dividend Yield0.12 %

Face Value₹ 1.00

Compounded Sales Growth (TTM)15%

Compounded Profit Growth (TTM)31%

Standalone figures.

Valuation

Market capRs 5,325 Cr

Enterprise valueRs 5,380 Cr

P/E (TTM)47.10x

Price to book5.67x

Price to sales4.87x

EV / EBITDA23.91x

EV / EBIT30.40x

EV / sales4.92x

Price to cash flow41.34x

Earnings yield2.12%

Dividend yield0.13%

P/E, 3-year average41.16x

P/B, 3-year average4.35x

P/E, 5-year average33.02x

P/B, 5-year average3.39x

Profitability

Operating margin (excl. other income)17.46%

Operating margin (incl. other income)19.99%

EBITDA margin20.59%

Pre-tax margin13.79%

Net profit margin10.35%

Net margin, latest quarter11.01%

ROE11.62%

ROCE14.27%

ROA7.48%

ROE, 3-year average11.99%

ROCE, 3-year average14.26%

ROA, 3-year average6.71%

ROE, 5-year average11.17%

ROCE, 5-year average12.87%

ROA, 5-year average6.05%

ROIC (approx.)13.29%

Tax rate25.41%

Other income / net worth2.86%

Growth

Sales growth (latest year)16.12%

Profit growth (latest year)23.94%

Sales CAGR, 3 years14.08%

Sales CAGR, 5 years21.41%

Profit CAGR, 3 years37.62%

Profit CAGR, 5 years70.93%

Sales growth QoQ3.00%

Profit growth QoQ5.08%

Sales growth YoY (latest quarter)12.89%

Profit growth YoY (latest quarter)44.96%

Per share

EPS (TTM)Rs 7.14

EPS (latest year)Rs 6.53

EPS (latest quarter)Rs 1.96

EPS, 3-year averageRs 5.41

EPS, 5-year averageRs 4.33

Book value per shareRs 59.29

Sales per shareRs 69.02

Cash flow per shareRs 8.14

Free cash flow per shareRs 1.58

Dividend per share (latest year)Rs 0.45

Dividend per share, 3-year averageRs 0.45

Dividend per share, 5-year averageRs 0.45

Dividends

Dividend payout6.88%

Dividend payout, 3-year average8.92%

Dividend payout, 5-year average10.49%

Efficiency

Asset turnover0.74x

Fixed asset turnover1.34x

Inventory turnover51.30x

Inventory days7 days

Debtor days38 days

Debtors turnover9.52x

Creditor days187 days

Cash conversion cycle38 days

Working capital days-19 days

Leverage

Total debtRs 260 Cr

Cash and bankRs 206 Cr

Net debtRs 55 Cr

Debt to equity0.28x

Net debt / EBITDA0.24x

Interest coverage6.74x

Current ratio (filing 2026-03-31)1.73x

Quick ratio (filing 2026-03-31)1.67x

Trade payables (filing 2026-03-31)Rs 96 Cr

Owners' fund to total sources65.94%

Debt to assets18.29%

Cash flow

Cash from Operating Activity (latest year)Rs 129 Cr

Cash from Investing Activity (latest year)Rs -96 Cr

Cash from Financing Activity (latest year)Rs -41 Cr

Net Cash Flow (latest year)Rs -8 Cr

Free cash flow (latest year)Rs 25 Cr

FCFE (approx.: FCF + change in debt)Rs 5 Cr

Cash from ops / profit, 5 years1.87x

Sales to cash flow8.23x

Statement figures

Net sales (TTM)Rs 1,093 Cr

Net sales (latest year)Rs 1,060 Cr

Sales (latest quarter)Rs 282 Cr

Operating profit excl. other income (latest year)Rs 185 Cr

Operating profit (latest quarter)Rs 55 Cr

Other income (TTM)Rs 25 Cr

EBITDA (TTM)Rs 225 Cr

PBDT (TTM)Rs 199 Cr

Profit before tax (TTM)Rs 151 Cr

Tax (latest year)Rs 35 Cr

Net profit (TTM)Rs 113 Cr

Net profit (latest year)Rs 103 Cr

Net profit (latest quarter)Rs 31 Cr

Depreciation (TTM)Rs 48 Cr

Depreciation (latest quarter)Rs 12 Cr

Interest (TTM)Rs 26 Cr

Cost of goods sold (latest year)Rs 667 Cr

Total expenditure (latest year)Rs 875 Cr

Total income (latest year)Rs 1,087 Cr

Share capitalRs 16 Cr

ReservesRs 923 Cr

Shareholders' fundsRs 939 Cr

Total assetsRs 1,424 Cr

Net blockRs 790 Cr

Capital work in progressRs 33 Cr

InvestmentsRs 15 Cr

ReceivablesRs 111 Cr

InventoryRs 13 Cr

Other liabilitiesRs 225 Cr

Shares outstanding (crore)15.83

Ownership

Promoter holding58.39% (-8.14 in a year)

Computed by MarketFriction from the standalone statements. Returns use average balances.

P/E 47.1 is at the 51th percentile of its own 6.8-year range (median 45.3, low 10.5, high 105.9).

P/B 5.67 is at the 72th percentile (median 3.75).

Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.

Period	ARTEMISMED	Nifty 50	Difference
1 week	+1.1%	-2.8%	+3.9 pts
1 month	+2.6%	-6.8%	+9.4 pts
3 months	+29.5%	-7.6%	+37.1 pts
6 months	+63.7%	+0.4%	+63.3 pts
1 year	+39.8%	-9.9%	+49.7 pts
2 years	+16.0%	-13.6%	+29.5 pts
3 years	+112.1%	+14.2%	+97.9 pts
5 years	+834.4%	+27.9%	+806.6 pts

9 mutual fund schemes hold about ₹64 Cr. Over three months 1 bought more and 8 sold (share counts, price move removed).

Fund	Weight	Est. Cr	3m shares
HSBC Focused Fund	2.15%	40	-13%
Bandhan Small Cap Fund	0.04%	15	-40%
JM ELSS-Tax Saver Fund	1.49%	4	+100%
LIC MF Healthcare Fund	2.88%	3	-17%
LIC MF Healthcare Fund	2.88%	3	-17%
Bandhan BSE Healthcare Index Fund	0.10%	0	-12%
LIC MF ULIS Regular Premium Uniform Cover Yrly 15Y	0.00%	0	-100%
LIC MF Children’s Fund	0.00%	0	-100%
Motilal Oswal BSE 1000 Index Fund	0.01%	0	-10%

Red flags

F-score 7 of 8

look	Share dilution Share count up 15% in a year, 18% in three
look	Auditor change Auditor change 2026-07-31: Artemis Medicare Services Limited has informed the Exchange regarding Change in Auditors of the company.

Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026

Sales ₹282 Cr +12.8% vs Jun 2025. Net profit ₹31 Cr +47.6%.

Against our estimate for Jun 2026: sales -3.7%, profit +8.2% beat. Our estimate for Sep 2026: sales Rs 310 Cr, profit Rs 34 Cr (how).

Activity

Compare

Company	Mcap (Cr)	P/E	ROCE
Apollo Hospitals Enterprise Ltd	124,503	59.2	17.4 %
Manipal Health Enterprises Ltd	98,357	111	12.1 %
Max Healthcare Institute Ltd	95,589	63.8	14.7 %
Aster DM Quality Care Ltd	63,976	177	11.6 %
Fortis Healthcare Ltd	62,058	58.2	13.4 %
Global Health Ltd	38,048	66.4	17.4 %
Narayana Hrudayalaya Ltd	36,579	42.4	15.5 %
Krishna Institute of Medical Sciences Ltd	32,336	155	9.50 %
Dr Agarwals Health Care Ltd	15,701	106	10.9 %
Rainbow Childrens Medicare Ltd	13,892	48.5	17.4 %
Park Medi World Ltd	11,898	42.8	19.5 %
Yatharth Hospital & Trauma Care Services Ltd	10,676	58.9	12.9 %
Healthcare Global Enterprises Ltd	10,505	218	8.30 %
Jupiter Life Line Hospitals Ltd	8,591	44.9	14.8 %
Kovai Medical Center & Hospital Ltd	6,579	25.7	22.6 %

No bulk or block deals on record.

Ex-date	Action	Factor
2026-07-10	Dividend - Re 0.45 Per Share
2025-07-11	Dividend - Re 0.45 Per Share
2024-07-05	Dividend - Rs 0.45 Per Share
2023-07-14	Dividend - Re 0.45 Per Share
2021-09-23	Face Value Split (Sub-Division) - From Rs 10/- Per Share To Re 1/- Per Share	0.1000
2021-07-12	Annual General Meeting
2020-09-15	Annual General Meeting

Date	Type	What it says
2026-09-29	Litigation	Artemis Medicare Services Limited has submitted to the Exchange a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requi...
2026-09-29	Litigation	Artemis Medicare Services Limited has submitted to the Exchange a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requi...
2026-09-24	Credit Rating	Credit Rating
2026-09-08	Concall / analyst meet	Analysts/ Institutional Investors Conference - September 22, 2026
2026-08-27	Concall / analyst meet	Analysts/ Institutional Investors Conference - September 3, 2026
2026-08-10	Concall / analyst meet	Transcript of Earnings Conference Call - Q1 FY27
2026-08-10	Concall / analyst meet	Analysts/ Institutional Investors Conference - August 13, 2026
2026-08-04	Concall / analyst meet	Audio Recording of Earnings Conference Call - Q1 FY27
2026-08-03	Monitoring Agency Report	Monitoring Agency Report for the quarter ended June 30, 2026
2026-08-03	Press Release	A press release dated August 03, 2026, titled "Artemis Consolidated Revenue from Operations up 12.7% in Q1 FY27 (YoY); EBITDA up 27.9%; Profit up 48...
2026-08-03	Investor Presentation	Investor Presentation
2026-08-03	Capacity addition	Proposed capacity expansion by adding 200+ beds through Tower IV in the Company s flagship Hospital located at Sector-51, Gurugram
2026-08-03	Board meeting outcome	Artemis Medicare Services Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
2026-08-03	Director change	Change in Director(s) of the company.
2026-07-31	Change in Auditors	Change in Auditors of the company.
2026-07-31	Director change	Change in Director(s) of the company.
2026-07-31	Shareholder meeting	Voting results.
2026-07-31	Shareholder meeting	Artemis Medicare Services Limited has submitted to the Exchange the proceedings of the 22nd Annual General Meeting held on July 31, 2026
2026-07-29	Concall / analyst meet	Schedule of Earnings Conference Call - Q1 FY27
2026-07-20	Shareholder meeting	Artemis Medicare Services Limited has submitted the Exchange Voting Results of Postal Ballot and Scrutinizers Report
2026-07-09	Commencement of commercial p	Commencement of Operations of Artemis Shanti Hospital, Raipur
2026-07-07	General Updates	Letter to shareholders containing weblink of Annual Report for the financial year 2025-26
2026-07-07	Updates	Business Responsibility and Sustainability Report for the financial year ended March 31, 2026.
2026-07-07	Shareholder meeting	Notice of Annual General Meeting to be held on July 31, 2026
2026-07-04	General Updates	Reminder letter to holders of physical securities for furnishing of KYC details.

Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.

No short selling reported to NSE in our files.

Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.

Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Artemis Medicare Services Ltd?

Artemis Medicare Services Ltd (ARTEMISMED) has a market capitalisation of Rs 5,818 Cr. at the 2026-10-01 close.

What is the P/E ratio of Artemis Medicare Services Ltd?

Artemis Medicare Services Ltd trades at a P/E of 50.4 on trailing twelve-month profit, at the 2026-10-01 close.

What were Artemis Medicare Services Ltd's latest quarterly results?

In the Jun 2026 quarter, Artemis Medicare Services Ltd sales was Rs 282 Cr (+12.8% vs Jun 2025) and net profit was Rs 31 Cr.

What is the 52-week high and low of Artemis Medicare Services Ltd?

The 52-week high is Rs 378.80 and the 52-week low is Rs 203.35.